Matt Kerr: Tough task ahead for APAC HR managers
Industry Insights | Opinion | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013
With rapid growth of life sciences industry in Asia, we have seen many success stories over the last decade. However, an...Read more
China Resources Sanjiu looks ahead at acquisitions for growth
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
To enhance its market opportunities and drive business growth, China Resources Sanjiu Medical & Pharmaceutical is ...Read more
United Labs boosts production to meet high demand
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
The global life science industry has been facing a financial crunch and The United Laboratories too has felt the jolt....Read more
Industry Insights | Opinion | By BioSpectrum Bureau | 0 Comment | 20 Nov, 2014
Singapore: The healthcare industry is at a disruptive stage globally and patient's involvement and engagement in their o...Read more
North China Pharma integrates R&D strength in its system
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 03 Jun, 2013
North China Pharmaceutical Company (NCPC) faced a decline of around 26 percent in 2012. The company is principally eng...Read more
Asia faces an acute skills gap challenge
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013
Shortage of skills and qualification among life science professionals to pursue risk laden activities is proving to be a...Read more
Mindray goes on acquisition spree for strong portfolio
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 22 Jun, 2012
Mindray Medical International is emerging as a global name in the medical devices industry, marking 25 percent growth in...Read more
Resmed dominates the niche sleep disorder market
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
A distinguished name in treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disor...Read more
Sinopharm demonstrates king size growth, yet again
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 31 May, 2013
Sinopharm, a dominant name in the distribution of pharmaceutical and healthcare products in China, continues to grab a...Read more
Cipla nurtures global vision for affordable drugs
Industry Insights | Analysis | By BioSpectrum Bureau | 3 Comment | 13 Jun, 2012
The king of generics, Cipla, has been aggressive in expanding product portfolio and reaching out to international market...Read more
Asia bioscience grows 11 percent, crosses $150 bn
Industry Insights | Analysis | By Nandita Singh | 0 Comment | 21 Jun, 2013
During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...Read more
Dr. Reddy's makes a mark in the US generics market
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
Striking profit on a high note, Dr. Reddy's crossed $1.5 billion worth of business in 2012, marking a growth of 22 per...Read more
Aurobindo Pharma revamps strategy to accelerate growth
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
Aurobindo Pharma, ranked among the top pharmaceutical company in India, clocked $1 billion revenue in 2012. Aurobindo ...Read more
ResMed builds on partnerships for growth
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 14 Jun, 2012
Driving in the niche industry of sleep disorders, ResMed was aggressive in strengthening its portfolio through acquisiti...Read more
Bioscience Industry clocks $139 bn, grows 8.37%
Industry Insights | Analysis | By Nandita Singh | 0 Comment | 03 Jul, 2012
The bioscience industry in the Asia Pacific region, in 2011, got pulled back into a low growth cycle. In a replay of 200...Read more
Sigma Pharma leverages on its pharmacy business
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 31 May, 2013
Marking a strong presence of 100 years in the pharmaceutical sector in the year 2012, Sigma Pharmaceuticals retained i...Read more
Shenzhen Neptunus invests in drug innovation
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
Shenzhen Neptunus Bioengineering is a well-recognized name in manufacturing and distribution of pharmaceutical product...Read more
China holds largest pharma revenue share in APAC
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
In 2011, China maintained its top position in the Asia Pacific's region for pharmaceutical industry, with the largest sh...Read more